HOME >> MEDICINE >> NEWS
Virginia Tech students discoveries can help prevent water-borne diseases

nd computer models to Mendocino. "Paolos research has given us a good understanding of the sources of our problems," Schott notes. "Hes the only person Ive found in the United States who does work in the field of dissolved gases and their impact on treatment."

In the plants Schott and Scardina have investigated, air bubble eruptions have carried solid particles into the filtration process, which leaves the treatment systems open to pathogen contamination. Schott is concerned about the potential for outbreaks of viruses, as well as Giardia and Cryptosporidium, both of which are microscopic parasites that can cause severe gastro-intestinal illness. These parasites are impervious to chlorine disinfection, so they must be removed through settling or filtration. A major water-borne outbreak of Cryptosporidium in Milwaukee in 1993 caused illness in an estimated 403,000 people.

These and other water-borne diseases are a threat whenever a treatment plant is compromised, which makes Scardinas research a potentially important human health tool.

In August, the AWWARF awarded a $150,000 grant to Scardina for continuation of his air bubble research. "Whats most impressive to me is that a conservative professional organization has been persuaded to fund a students original research," Edwards says. "Its unusual for a Ph.D. student to lead an effort that wins a competitive grant through AWWARFs unsolicited proposal process."

Scardina will use the grant to "get a handle on the magnitude of the problem," he says. Working with treatment plant engineers, he is investigating air bubbles in Boulder and Denver, Colorado; Bay City, Michigan; San Diego, California; Myrtle Beach, South Carolina; and Buffalo Pound in Canada. "Im studying parameterssuch as treatment plant design and operationsthat can affect formation of bubbles."

After he completes his Ph.D. in another year or so, Scardina wants to work in the water treatment industry and continue h
'"/>

Contact: Dr. Marc Edwards
edwardsm@vt.edu
540-231-7236
Virginia Tech
5-Oct-2001


Page: 1 2 3 4

Related medicine news :

1. Melanoma vaccine developed at the University of Virginia shows promise in clinical trial
2. Wayne State and Virginia chemist wins national award for work with drugs
3. New cold treatment developed at the University of Virginia
4. From preventing disease to softening our ride, Virginia Tech inventions and creations can improve lives
5. Many Virginians would increase taxes for K-12 education, study finds
6. Commercial Scale Cultivation Of Pharmaceutical-Producing Tobacco Possible, Virginia Tech Scientists Find
7. Enhancing Night Visibility Using UV Technology To Be Tested On Virginia Techs Smart Road
8. College students at no greater risk of alcohol-related problems than peers
9. Tobacco-company-sponsored parties with free cigarettes may encourage students to start smoking
10. Dairy Council of California program receives high marks from teachers & students
11. Scholarship to attract top students for optometry

Post Your Comments:
(Date:5/17/2013)... Goodman HealthDay Reporter , , FRIDAY, May 17 (HealthDay ... a metal detector, a musical instrument and a GPS system, ... your life if you,re having a heart attack. The ... helps doctors rapidly diagnose certain kinds of severe heart attacks, ... app currently is in the experimental stage, but it has ...
(Date:5/17/2013)... Lake Arrowhead, CA (PRWEB) May 17, 2013 ... without extra health complications, but for diabetics, treatment is ... diabetics involves additional medical care to monitor blood sugar ... an addicted diabetic properly, a drug rehab for ... the unique dietary and nutritional needs of the diabetic, ...
(Date:5/17/2013)... being openly gay appears to affect a male ... on his performance, according to a new study. ... Carolina found that an actor who is "out" ... despite stereotypes about homosexuals. "Early research showed ... between sexual orientation and established gender roles, especially ...
(Date:5/17/2013)... Liver transplants to treat a common type of liver ... HIV, according to new research. The Italian study, ... , found that the AIDS-causing virus doesn,t affect survival ... with this particular type of liver cancer, called hepatocellular ... is more aggressive in people with HIV and it ...
(Date:5/17/2013)... GA (PRWEB) May 17, 2013 The ... news on the site for women using the vaginal ... panel shows the number of claims alleging blood clots ... was created to improve the safety of patients using ... research and legal news. Visitors can find out if ...
Breaking Medicine News(10 mins):Health News:Heart Attack? Doctors Soon May Have an App for That 2Health News:Heart Attack? Doctors Soon May Have an App for That 3Health News:Above It All Treatment Center Helps Drug Addicts who are Type I and Type II Diabetics 2Health News:Above It All Treatment Center Helps Drug Addicts who are Type I and Type II Diabetics 3Health News:Gay Actors Convincing in Heterosexual Roles 2Health News:HIV No Barrier to Getting Liver Transplant, Study Finds 2Health News:Latest Court Records Show 6% Increase In NuvaRing Lawsuits, DrugRisks Notes 2
(Date:5/16/2013)... , May 17, 2013 ... and Switzerland,s Cytos Biotechnology AG today ... a Phase 1 clinical trial with their H1N1 influenza vaccine ... technology. In this first Phase 1 clinical trial, the safety ... to protect against H1N1 influenza infection will be evaluated. ...
(Date:5/16/2013)... and SYDNEY , May 16, ... - ASX: HIN), a leading innovator of less invasive, miniaturized ... heart failure, today announced that CEO Doug Godshall ... Global Healthcare Conference at 11:00 a.m. EDT on Monday, May ... at the Sheraton New York Hotel. A live ...
(Date:5/16/2013)... 16, 2013  ULURU Inc. (OTCQB: ULUR) today announced its ... and provided a review of its operating activities. ... the previously communicated outlook for 2013: , Launching Altrazeal ... network of distribution partners to cover all major markets excluding ... ® to be marketed in approximately 50 markets by ...
Breaking Medicine Technology:A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 2A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 3A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 4A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 5A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 6HeartWare Presentation At The 2013 UBS Global Healthcare Conference To Be Webcast 2ULURU Inc. Reports First Quarter 2013 Financial Results 2ULURU Inc. Reports First Quarter 2013 Financial Results 3ULURU Inc. Reports First Quarter 2013 Financial Results 4ULURU Inc. Reports First Quarter 2013 Financial Results 5
Cached News: